
LUNGevity Foundation/LinkedIn
Jul 24, 2025, 18:06
What Are Orphan Drugs, and How Can They Be Leveraged for SCLC? – LUNGevity Foundation
LUNGevity Foundation shared a post on LinkedIn:
“What are orphan drugs, and how can they be leveraged for small cell lung cancer?
Read our latest blog with dedicated researcher and oncologist, Noura Choudhury, MD, at the University of Chicago, as she searches for better treatments for lung cancer.”
More posts featuring LUNGevity Foundation.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 24, 2025, 17:45
Jul 24, 2025, 17:32
Jul 24, 2025, 17:24
Jul 24, 2025, 17:20
Jul 24, 2025, 17:03
Jul 24, 2025, 16:38